Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1.Nusinersen[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
22011-2012 seasonal flu vaccine Intramuscular----[2] 3, 113 💬
32011-2012 seasonal flu vaccine Subcutaneous----[2] 3, 113 💬
43,4-Diaminopyridine Phosphate----[1] 3 💬
54-aminopyridine----[2] 3, 13 💬
64-cholesten-3-one, oxime[1] Olesoxime[1] Olesoxime 💬 --[2] 2, 3 💬
74-cholesten-3-one,oxime----[1] 3 💬
8[ ISIS 396443, BIIB058]----[1] 3 💬
9[0000]----[1] 3 💬
10[Amifampridina fosfato]----[2] 3, 11 💬
11[AVXS-101]----[1] 3 💬
12[BHV-2000]----[1] 3 💬
13[ISIS 396443 BIIB058]----[1] 3 💬
14[ISIS 396443, BIIB058]----[1] 3 💬
15[NA]----[34] 3, 6, 11, 13, 14, 19, 28, 35, 41, 46, 49, 50, 53, 57, 62, 63, 65, 75, 79, 85, 90, 96, 97, 98, 113, 127, 162, 195, 223, 229, 251, 294, 299, 302 💬
16[NMD670]----[1] 3 💬
17[OAV101]----[1] 3 💬
18[RO7034067/F12]----[1] 3 💬
19[RO7034067/F13]----[1] 3 💬
20[RO7034067]----[1] 3 💬
21[RO7204239/F01-01]----[1] 3 💬
22[SRK-015]----[1] 3 💬
23Adipose derived mesenchymal stem cell----[1] 3 💬
24AMIFAMPRIDINA----[2] 3, 11 💬
25Amifampridina fosfato----[2] 3, 11 💬
26Amifampridine[1] Amifampridine[2] Amifampridine ,
Amifampridine phosphate 💬 		[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[3] 3, 11, 12 💬
27Amifampridine Phosphate[1] Amifampridine[2] Amifampridine ,
Amifampridine phosphate 💬 		[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[3] 3, 11, 12 💬
28Amifampridine Phosphate 10 MG Oral Tablet[1] Amifampridine[2] Amifampridine ,
Amifampridine phosphate 💬 		[7] KCNA1,
KCNA2,
KCNA4,
KCNA6,
KCNC3,
KCND2,
KCND3 💬 		[5] Cortisol synthesis and secretion, Cushing syndrome, IgSF CAM signaling, Serotonergic synapse, Spinocerebellar ataxia 💬[1] 3 💬
29Apitegromab[1] Apitegromab[1] Apitegromab 💬 [1] MSTN 💬 [1] Cytokine-cytokine receptor interaction 💬[2] 3, 113 💬
30ARGX-119[1] ARGX-119---[3] 2, 3, 12 💬
31ARGX-119 IV[1] ARGX-119---[1] 3 💬
32AVXS-101----[1] 3 💬
33AVXS-101 (previously known as scAAV9.CB.SMN)----[1] 3 💬
34BHV-2000----[1] 3 💬
35BIIB115[1] BIIB115---[1] 3 💬
36Biocarn----[1] 3 💬
37Biocollection----[1] 3 💬
38Blood draw----[16] 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
39Blood sample----[33] 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
40Blood sampling----[15] 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
41Branaplam[1] Branaplam[1] Branaplam 💬 --[2] 3, 8 💬
42Calcium[1] Calcium---[39] 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
43CELECOXIB[1] Celecoxib[1] Celecoxib 💬 [1] PTGS2 💬 [22] Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬[14] 2, 3, 6, 13, 34, 46, 70, 89, 96, 97, 107, 161, 171, 271 💬
44Creatine[1] Creatine---[18] 1, 2, 3, 5, 6, 8, 13, 15, 21, 46, 49, 50, 97, 113, 156, 201, 256, 337 💬
45Diagnostic Test: Beck depression inventory fast screen (Questionnaire)----[3] 3, 15, 256 💬
46Diagnostic Test: Borg Scale----[3] 3, 15, 256 💬
47Diagnostic Test: Brief Pain Inventory (BPI) (Questionnaire)----[3] 3, 15, 256 💬
48Diagnostic Test: Fatigue Severity and Disability Scale (FSS) (Questionnaire)----[3] 3, 15, 256 💬
49Diagnostic Test: German Pain Inventory (Questionnaire)----[3] 3, 15, 256 💬
50Diagnostic Test: Handheld Dynamometry (HHD)----[3] 3, 15, 256 💬
51Diagnostic Test: Laboratory assessment: calcium[1] Calcium---[3] 3, 15, 256 💬
52Diagnostic Test: Laboratory assessment: Creatine kinase[1] Creatine---[3] 3, 15, 256 💬
53Diagnostic Test: Laboratory assessment: magnesium[1] Magnesium---[3] 3, 15, 256 💬
54Diagnostic Test: Laboratory assessment: phosphate----[3] 3, 15, 256 💬
55Diagnostic Test: Laboratory assessment: Vitamin D Level[1] Vitamin D---[3] 3, 15, 256 💬
56Diagnostic Test: Muscle ultrasound----[5] 3, 15, 111, 113, 256 💬
57Diagnostic Test: Pressure pain threshold----[4] 3, 15, 113, 256 💬
58Diagnostic Test: Quick Motor Function Test----[4] 3, 15, 113, 256 💬
59Diagnostic Test: R-PAct (Questionnaire)----[3] 3, 15, 256 💬
60Diagnostic Test: Rotterdam Handicap Scale (RHS) (Questionnaire)----[3] 3, 15, 256 💬
61Diagnostic Test: Six-minute walk test (6MWT)----[3] 3, 15, 256 💬
62Diagnostic Test: Vital signs----[3] 3, 15, 256 💬
63Disease modifying treatments----[1] 3 💬
64EVRYSDI----[1] 3 💬
65EvrysdiPharmaceutical Form: Powder for oral solutionINN or Proposed INN: RisdiplamCurrent Sponsor code: RO7034067Concentration unit: mg milligram(s)Concentration type: equalConcentration number: 60-----[1] 3 💬
66EXG001-307 injection----[1] 3 💬
67FIRDAPSE - 10 MG - COMPRESSE - USO ORALE - BLISTER(ALU/PVC/PVDC) 100 X 1 COMPRESSE----[2] 3, 11 💬
68GB221----[1] 3 💬
69Genetic: ANB-004, dose 1----[1] 3 💬
70Genetic: ANB-004, dose 2----[1] 3 💬
71Genetic: ANB-004, dose 3----[1] 3 💬
72Genetic: AVXS-101----[1] 3 💬
73Genetic: Blood draw for optional genetic exome sequencing----[3] 3, 15, 256 💬
74Genetic: EXG001-307 injection----[1] 3 💬
75Genetic: GC101----[1] 3 💬
76Genetic: GC101 adeno-associated virus injection----[1] 3 💬
77Genetic: GCB-001----[1] 3 💬
78Genetic: Genetic test: ACE polymorphism----[3] 3, 15, 256 💬
79Genetic: Genetic test: ACTN3 polymorphism----[3] 3, 15, 256 💬
80Genetic: OAV101----[1] 3 💬
81Genetic: SKG0201 Injection----[1] 3 💬
82GH----[1] 3 💬
83GYM329[1] GYM329---[2] 3, 113 💬
84HUMAN ANTI-PROMYOSTATIN MONOCLONAL ANTIBODY----[1] 3 💬
85Hydroxyurea[1] Hydroxyurea[1] Hydroxyurea 💬 [1] RRM2 💬 [5] Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism, p53 signaling pathway 💬[10] 3, 13, 19, 20, 46, 65, 85, 86, 107, 284 💬
86Interlaminar ultrasound-assisted intrathecal administration of nusinersen[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
87ISIS 396443----[1] 3 💬
88ISIS 396443 (BIIB058)----[1] 3 💬
89ISIS 396443, BIIB058----[1] 3 💬
90Itraconazole[1] Itraconazole[1] Itraconazole 💬 --[13] 2, 3, 6, 46, 65, 67, 96, 97, 137, 158, 227, 299, 309 💬
91Landmark-based intrathecal administration of nusinersen[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
92Leuprolide[1] Leuprolide[3] Leuprolide acetate ,
Leuprolide ,
Leuprolide mesylate 💬 		[1] GNRHR 💬 [3] GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬[5] 1, 2, 3, 51, 76 💬
93LEVOCARNITINE[1] Levocarnitine[2] Levocarnitine chloride ,
Levocarnitine 💬 		--[3] 3, 53, 97 💬
94LMI070----[2] 3, 8 💬
95Magnesium[1] Magnesium---[23] 3, 6, 11, 13, 15, 46, 64, 70, 71, 93, 97, 113, 166, 225, 234, 235, 256, 284, 291, 296, 297, 298, 340 💬
96Mestinon----[3] 3, 6, 11 💬
97Midazolam[1] Midazolam[3] Midazolam ,
Midazolam hydrochloride ,
Midazolam maleate 💬 		[16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[14] 2, 3, 6, 13, 21, 46, 67, 70, 96, 97, 231, 272, 298, 299 💬
98N.a.----[11] 3, 6, 8, 13, 46, 63, 96, 97, 240, 256, 271 💬
99N/AProduct Code: RO7204239/F01-01Pharmaceutical Form: Solution for injectionINN or Proposed INN: N/ACAS Number: N/ACurrent Sponsor code: RO7204239Other descriptive name: GYM329Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 80-Pharmaceutical form of the placebo: Solution for injectionRoute of administration of the placebo: Subcutaneous use----[1] 3 💬
100Nerve Growth Factor[1] Nerve Growth Factor---[5] 2, 3, 18, 53, 90 💬
101NMD670----[3] 3, 10, 11 💬
102Norditropin SimpleXx----[5] 3, 97, 107, 193, 195 💬
103Norditropin SimpleXx 15 mg/1.5 ml----[1] 3 💬
104Nursinersen----[1] 3 💬
105NUSINERSEN[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
106Nusinersen Injectable Product[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
107NUSINERSEN SODIUM[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
108Nusinersen Treatments[1] Nusinersen[2] Nusinersen sodium ,
Nusinersen 💬 		--[1] 3 💬
109OAV101----[1] 3 💬
110Observational study to examine safety, tolerability, and effectiveness of SPINRAZA® prescribed as part of standard of care----[1] 3 💬
111Okrido----[1] 3 💬
112Okrido 6mg/mL oral solution----[1] 3 💬
113Olesoxime[1] Olesoxime[1] Olesoxime 💬 --[3] 2, 3, 13 💬
114ONASEMNOGENE ABEPARVOVEC[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
115Onasemnogene Abeparvovec-brve[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
116Onasemnogene Abeparvovec-xioi[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
117Orfiril Saft----[1] 3 💬
118Other: Assessment of activity and muscle fatigue----[1] 3 💬
119Other: Assessment of bulbar function----[1] 3 💬
120Other: Blood Samples----[13] 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
121Other: Blood sampling for biomarker analysis----[1] 3 💬
122Other: Cardiac evaluation----[1] 3 💬
123Other: Electrophysiology measurements----[1] 3 💬
124Other: Evaluation of body composition and metabolism----[1] 3 💬
125Other: evaluation of muscle function----[1] 3 💬
126Other: First-line cognitive assessment----[1] 3 💬
127Other: Gait analysis via video capture----[2] 3, 113 💬
128Other: GIP + GLP-2----[2] 3, 113 💬
129Other: Meal test----[2] 3, 113 💬
130Other: Mobility study in dry conditions----[1] 3 💬
131Other: Mobility study in water conditions[1] Water[1] Water 💬 --[1] 3 💬
132Other: Monthly assessments of functional motor abilities by a trained therapist----[1] 3 💬
133Other: MRI----[4] 3, 13, 127, 206 💬
134Other: Muscle MRI----[2] 3, 10 💬
135Other: Onasemnogene Abeparvovec[1] Onasemnogene abeparvovec[1] Onasemnogene abeparvovec 💬 --[1] 3 💬
136Other: One time survey----[1] 3 💬
137Other: Prospective observational registry----[1] 3 💬
138Other: Questionnaires----[8] 3, 6, 13, 41, 46, 77, 96, 226 💬
139Other: second-line cognitive assessment----[1] 3 💬
140Other: Skinfold measurement----[1] 3 💬
141Other: Strength, function and activity measurements----[1] 3 💬
142PARACETAMOL----[6] 3, 6, 13, 28, 46, 48 💬
143Paracetamol 120Mg/5mL Oral Suspension----[1] 3 💬
144PREDNISOLONE[1] Prednisolone[1] Prednisolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[48] 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
145PREDNISOLONE SODIUM PHOSPHATE[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone ,
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 3, 13, 97 💬
146Prednisolone Sodium Phosphate Oral Solution[2] Prednisolone,
Prednisolone phosphate		[2] Prednisolone ,
Prednisolone sodium phosphate 💬 		[1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 3 💬
147Previously termed sc.AAV9.CB.SMN and AVXS-101----[1] 3 💬
148Propofol[1] Propofol[1] Propofol 💬 [16] GABRA1,
GABRA2,
GABRA3,
GABRA4,
GABRA5,
GABRA6,
GABRB1,
GABRB2,
GABRB3,
GABRD,
GABRE,
GABRG1,
GABRG2,
GABRG3,
GABRP,
GABRQ 💬 		[9] Cadherin signaling, GABAergic synapse, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬[10] 3, 6, 21, 22, 34, 46, 70, 97, 98, 296 💬
149Pyridostigmine[1] Pyridostigmine[1] Pyridostigmine bromide 💬 [1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[5] 3, 6, 11, 51, 256 💬
150Pyridostigmine Bromide[1] Pyridostigmine[1] Pyridostigmine bromide 💬 [1] ACHE 💬 [3] Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬[5] 3, 6, 11, 51, 256 💬
151Radiation: MRI----[1] 3 💬
152RELDESEMTIV[1] Reldesemtiv[1] Reldesemtiv 💬 [3] TNNC2,
TNNI2,
TNNT3 💬 		[3] Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬[2] 2, 3 💬
153Reldesemtiv 150 mg[1] Reldesemtiv[1] Reldesemtiv 💬 [3] TNNC2,
TNNI2,
TNNT3 💬 		[3] Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬[1] 3 💬
154Reldesemtiv 450 mg[1] Reldesemtiv[1] Reldesemtiv 💬 [3] TNNC2,
TNNI2,
TNNT3 💬 		[3] Calcium signaling pathway, Cytoskeleton in muscle cells, Motor proteins 💬[1] 3 💬
155RILUZOLE[1] Riluzole[1] Riluzole 💬 [14] GRIA1,
GRIA2,
GRIA3,
GRIA4,
GRIK1,
GRIK2,
GRIK3,
GRIK4,
GRIK5,
GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		[24] Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬[9] 2, 3, 5, 8, 13, 17, 18, 203, 206 💬
156Risdiplam[1] Risdiplam[1] Risdiplam 💬 --[1] 3 💬
157RO6885247----[1] 3 💬
158RO6885247/F02----[1] 3 💬
159RO6885247/F03----[1] 3 💬
160RO7034067----[1] 3 💬
161RO7034067 / F12----[1] 3 💬
162RO7034067 / F13----[1] 3 💬
163RO7034067/F06 + solvente (RO----[1] 3 💬
164RO7034067/F06 with solvent (RO7034067/F08)----[1] 3 💬
165RO7034067/F07 + solvente (RO----[1] 3 💬
166RO7034067/F07 with solvent (RO7034067/F09)----[1] 3 💬
167RO7034067/F12----[1] 3 💬
168RO7034067/F13----[1] 3 💬
169RO7090919----[1] 3 💬
170RO72042369/F03-01----[1] 3 💬
171RO7204239----[2] 3, 113 💬
172RO7204239/F01-01----[1] 3 💬
173RO7204239/F03-01----[1] 3 💬
174RVG 03820----[1] 3 💬
175Salanersen----[1] 3 💬
176Salbutamol----[9] 2, 3, 11, 85, 86, 228, 256, 299, 340 💬
177Sesame oil[1] Sesame oil[1] Sesame oil 💬 --[1] 3 💬
178SESAME OIL, REFINED[1] Sesame oil[1] Sesame oil 💬 --[1] 3 💬
179Sham control----[1] 3 💬
180Sham Procedure----[3] 3, 201, 339 💬
181Sodium phenylbutyrate[1] Phenylbutyric acid[1] Sodium phenylbutyrate 💬 --[5] 2, 3, 8, 18, 251 💬
182Somatotropin[1] Somatotropin[1] Somatropin 💬 [1] GHR 💬 [6] Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬[3] 3, 65, 236 💬
183Somatropin----[14] 3, 74, 75, 78, 97, 107, 113, 187, 193, 195, 222, 238, 274, 276 💬
184Spinraza----[1] 3 💬
185SRK-015----[1] 3 💬
186Survival of Motor Neuron 2 (SMN2) Splicing Modulator Antisense Oligonucleotide----[1] 3 💬
187Taldefgrobep alfa----[1] 3 💬
188Taldefgrobep alfa Product Code: BHV-2000Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: Taldefgrobep alfaCurrent Sponsor code: BHV-2000Concentration unit: ml millilitre(s)Concentration type: equalConcentration number: 35-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous useProduct Name: taldefgrobep alfa Product Code: BHV-2000Pharmaceutical Form: Solution for injection in pre-filled syringeINN or Proposed INN: Taldefgrobep alfaCurrent Sponsor code: BHV-2000Concentration unit: ml millilitre(s)Concentration type: equalConcentration number: 50-Pharmaceutical form of the placebo: Solution for injection in pre-filled syringeRoute of administration of the placebo: Subcutaneous use----[1] 3 💬
189Testosterone[1] Testosterone[1] Testosterone 💬 [1] AR 💬 [4] Chemical carcinogenesis - receptor activation, Oocyte meiosis, Pathways in cancer, Prostate cancer 💬[9] 1, 2, 3, 13, 60, 76, 78, 113, 265 💬
190ThecaFlex DRx System----[1] 3 💬
191TRO19622----[2] 2, 3 💬
192VALPROATE SODIUM[1] Valproic acid[3] Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
193Valproate, Levocarnitine[1] Levocarnitine[2] Levocarnitine chloride ,
Levocarnitine 💬 		--[1] 3 💬
194Valproic Acid[1] Valproic acid[3] Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[10] 3, 5, 26, 34, 65, 89, 90, 145, 222, 331 💬
195Valproic Acid (VPA)[1] Valproic acid[3] Divalproex sodium ,
Valproic acid ,
Valproate sodium 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
196Valproic Acid and Levocarnitine[2] Levocarnitine,
Valproic acid		[5] Divalproex sodium ,
Valproic acid ,
Valproate sodium ,
Levocarnitine chloride ,
Levocarnitine 💬 		[7] ABAT,
ALDH5A1,
CACNA1G,
CACNA1H,
CACNA1I,
GAD1,
GAD2 💬 		[16] Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬[1] 3 💬
197Vesemnogene lantuparvovec----[1] 3 💬
198Vitamin D[1] Vitamin D---[26] 3, 6, 13, 15, 19, 41, 43, 44, 46, 49, 50, 68, 74, 93, 95, 96, 97, 98, 179, 222, 228, 235, 256, 274, 298, 299 💬
199VOLMAX*30CPR 4MG R.P.----[1] 3 💬
200Water[1] Water[1] Water 💬 --[36] 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
201Zolgensma----[1] 3 💬
202Zolgensma 2 x 1013 vector genomes/mL solution for infusion----[1] 3 💬
203Zolgensma 2 x 1013 vg (genomi vettoriali)/ml soluzione per infusione----[1] 3 💬
204Zolgensma 2 x 1013 vg (vector genomes)/mL solution for infusion----[1] 3 💬